FDA approves new treatment for sickle cell disease
Sunday, July 9, 2017 - 10:42
in Health & Medicine
The U.S. Food and Drug Administration today approved Endari (L-glutamine oral powder) for patients age five years and older with sickle cell disease to reduce severe complications associated with the blood disorder. “Endari is the ... Read more